1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Dose Optimization and Efficacy Assessment of a Fluoropyrimidine Antidotecancer, neoplasmNot yet recruitingPhase 1 / Phase 22025-06-22NCT07032142